dc.contributor.author
Miralbell Blanch, Júlia
dc.contributor.author
Spulber, Gabriela
dc.contributor.author
Hooshmand, Babak
dc.contributor.author
Besga, Ariadna
dc.contributor.author
Mataró Serrat, Maria
dc.contributor.author
Cedazo-Mínguez, Ángel
dc.contributor.author
Kivipelto, Miia
dc.contributor.author
Wahlund, Lars-Olof
dc.date.accessioned
2026-01-27T05:17:57Z
dc.date.available
2026-01-27T05:17:57Z
dc.date.issued
2026-01-26T17:32:38Z
dc.date.issued
2026-01-26T17:32:38Z
dc.date.issued
2026-01-26T17:32:38Z
dc.identifier
https://hdl.handle.net/2445/226185
dc.identifier.uri
http://hdl.handle.net/2445/226185
dc.description.abstract
The aim of this study was to investigate brain tissue volumes, grey matter (GM) distribution, and cognitive performance for cognitively impaired subjects using cerebrospinal fluid (CSF) biomarker cut-offs as grouping criteria. 41 subjects attending the Memory Clinic, Karolinska University Hospital, Huddinge, Sweden, were divided into groups based on normal or abnormal CSF levels of Aβ1-42, t-tau, and p-tau181. SIENAX algorithms were employed for brain tissue volumes estimation and voxel-based morphometry (VBM) for mapping the differences in GM patterns. VBM revealed significant lower GM volumes in temporo-parietal, occipital, and prefrontal cortices for those subjects belonging to abnormal CSF t-tau and p-tau181 groups. No differences were found between groups according to CSF Aβ1-42 cut-offs. Patients with abnormal CSF p-tau181 showed lower cognitive performance compared to those with normal levels. Patients with abnormal levels of CSF tau (but not Aβ1-42) showed an Alzheimer's disease-like pattern for both GM distribution and cognitive profile, compared to those with normal levels. These results support the hypothesis that CSF t-tau or p-tau181 levels may be of direct value for the evaluation of disease severity.
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.3233/JAD-2012-111553
dc.relation
Journal of Alzheimer's Disease, 2012, vol. 29, num.4, p. 741-749
dc.relation
https://doi.org/10.3233/JAD-2012-111553
dc.rights
(c) Miralbell, J. et al., 2012
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Marcadors bioquímics
dc.subject
Trastorns de la cognició
dc.subject
Biochemical markers
dc.subject
Cognition disorders
dc.title
Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion